SAng Moo Kang

University of Georgia

United States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Collaborators (6)

Bao-Zhong Wang

UNITED STATES

Ramireddy Bommireddy

Assistant Professor

Emory University School of Medicine

UNITED STATES

Chong Shin

University of Georgia

UNITED STATES

Periasamy Selvaraj

Emory University

UNITED STATES

Phillip Grovenstein

Georgia College & State University

UNITED STATES

Mukesh Kumar

Assistant Professor

University of Georgia

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

SAng Moo Kang

Research Interests

Explore related searches

Contact this professor

Articles (17)

Collaborators (6)

Bao-Zhong Wang

Ramireddy Bommireddy

Chong Shin

Periasamy Selvaraj

Phillip Grovenstein

Mukesh Kumar

Make your next move.

SAng Moo Kang

Research Interests

Explore related searches

Contact this professor

Articles (17)

Interferon-γ receptor signaling is critical for balanced immune activation and protection against influenza after vaccination

Lipid nanoparticles encapsulating both adjuvant and antigen mRNA improve influenza immune cross-protection in mice

Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination

Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants

Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines

Influenza immune imprinting synergizes PEI-HA/CpG nanoparticle vaccine protection against heterosubtypic infection in mice

Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination

Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles

Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses

A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine

Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses

Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination

Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei

Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery

Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle

Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity

Collaborators (6)

Bao-Zhong Wang

Ramireddy Bommireddy

Chong Shin

Periasamy Selvaraj

Phillip Grovenstein

Mukesh Kumar

Make your next move.